Search

everythinglearnresearchcommunity

for

Search:↓

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Skin stem cells were turned into heart cells using a chemical, suggesting a new way to treat heart attacks.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Treatments for hair loss include estrogen therapy and special shampoos.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.